Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By
Real members of MyBCTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Cymbalta recall The Daily Mail

A MyBCTeam Member asked a question 💭
Rochester, NY

Some women on here may be using Cymbalta for neuropathy.

“More than 370,000 bottles of duloxetine delayed-release capsules, sold by New Jersey-based Breckenridge Pharmaceuticals and commonly known as Cymbalta, were subject to the warning.

The FDA raised the alarm after tests found the capsules contained higher than permitted levels of N-nitroso-duloxetine, which is considered to be a probable carcinogen to humans.“

June 16 (edited)
 · 
Reactions
A MyBCTeam Member

I spoke to my pharmacist and she said since my brand was from a different manufacturer I am not affected by the recall. So please contact your pharmacist regarding the recall to see if your medication is on the list.

June 17
MyBCTeam

Is there a Cymbalta (duloxetine) recall that breast cancer patients using it for neuropathy should know about?

This is a really important thing to flag for the community. While the search results available don't contain specific details about a current Cymbalta recall, here's what to do right away:

- Check the FDA's Show Full Answer

Is there a Cymbalta (duloxetine) recall that breast cancer patients using it for neuropathy should know about?

This is a really important thing to flag for the community. While the search results available don't contain specific details about a current Cymbalta recall, here's what to do right away:

- Check the FDA's recall database at fda.gov for the most up-to-date recall information
- Contact your oncologist or pharmacist immediately — they will have the latest safety alerts
- Do not stop taking Cymbalta suddenly without medical guidance, as stopping abruptly can cause withdrawal symptoms

Chemotherapy-induced peripheral neuropathy (CIPN) is a real and common challenge for those on breast cancer treatments like taxanes or hormone therapies. If Cymbalta needs to be stopped, a doctor can help find an alternative to manage nerve pain safely.

Reaching out to the oncology team as soon as possible is the best step anyone in this situation can take.

June 16
A MyBCTeam Member

The recall affects multiple batches of duloxetine delayed-release capsules, with specific lots identified as Lot 241069C and Lot 241180C, which are set to expire on May 31, 2027

June 16
A MyBCTeam Member

I heard about the recall I am trying to get an answer I am still taking it myself. I will let you know once I find out.

June 16
A MyBCTeam Member

If you decide to discontinue Duloxetine use, cold turkey is not recommended (withdrawal symptoms can be very severe).

June 16

Related Questions

View All

Cymbalta recall.

A MyBCTeam Member asked a question 💭
Rochester, NY
November 16, 2025

The Importance of Trusting Yourself
The Art of Redefining Ourselves
Breast Cancer Spreading to the Lungs: 4 Symptoms and Treatment